Tihui Fu
- Immunology top 2%
- Immunotherapy and Immune Responses 16
- Immune Cell Function and Interaction 11
- T-cell and B-cell Immunology 6
- Immune Response and Inflammation 2
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 8
- Viral-associated cancers and disorders 4
- CAR-T cell therapy research 2
-
- RNA Interference and Gene Delivery 2
Tihui Fu
21 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 82
- Immunology 1.2k
- Oncology 743
- Pathology and Forensic Medicine 109
- Immunology and Allergy 36
- Molecular Biology 387
Countries citing papers authored by Tihui Fu
This map shows the geographic impact of Tihui Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tihui Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tihui Fu more than expected).
Fields of papers citing papers by Tihui Fu
This network shows the impact of papers produced by Tihui Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tihui Fu. The network helps show where Tihui Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tihui Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 35 | |
| 2 | 2018 | 62 | |
| 3 | 2018 | 8 | |
| 4 | 2016 | 49 | |
| 5 | 2016 | 81 | |
| 6 | 2014 | 1 | |
| 7 | 2013 | 44 | |
| 8 | 2011 | 193 | |
| 9 | ICOS/ICOSL経路は,抗CTLA-4療法によってもたらされる最適な抗腫瘍効果に必要である | 2011 | 2 |
| 10 | 2011 | 23 | |
| 11 | 2008 | 149 | |
| 12 | Toll-Like Receptor 8-Mediated Reversal of CD4 + Regulatory T Cell Functionbreakdown → | 2005 | 603 |
| 13 | 2004 | 120 | |
| 14 | 2004 | 50 | |
| 15 | 2004 | 12 | |
| 16 | 2004 | 7 | |
| 17 | 2002 | 78 | |
| 18 | Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells. | 2002 | 50 |
| 19 | 2002 | 18 | |
| 20 | 2000 | 20 |
About Tihui Fu
Tihui Fu is a scholar working on Immunology, Oncology and Microbiology, having authored 21 papers that have together received 1.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (16 papers), Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (8 papers), T-cell and B-cell Immunology (6 papers), Viral-associated cancers and disorders (4 papers), CAR-T cell therapy research (2 papers), Immune Response and Inflammation (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (743 citations) and Pathology and Forensic Medicine (109 citations). Tihui Fu has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Kui Shin Voo, Padmanee Sharma, Helen Y. Wang, Rongfu Wang, Qiuming He, Yanchun Li, Zhong Guo, Guangyong Peng, Weiyi Peng and Yukiko Kiniwa. Their work appears in journals such as Journal of Clinical Investigation, Cancer Research, Cancer Immunology Research, Journal of Clinical Oncology and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.